Literature DB >> 3697654

Adjuvant radiotherapy and chemotherapy in breast cancer.

C S McArdle, D Crawford, E H Dykes, K C Calman, D Hole, A R Russell, D C Smith.   

Abstract

Three hundred and twenty-two women with involvement of axillary lymph nodes following surgery for operable breast cancer were randomized to receive either postoperative radiotherapy, chemotherapy (CMF) or radiotherapy followed by chemotherapy. There was an increase in disease free interval in pre- and postmenopausal patients receiving radiotherapy and chemotherapy regardless of the number of nodes involved. However, there was a trend towards an improvement in disease related survival only in those patients with more than three nodes involved.

Entities:  

Mesh：

Year:  1986        PMID： 3697654     DOI： 10.1002/bjs.1800730407

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


  9 in total

1.  Psychosocial effects of radiotherapy after mastectomy.

Authors:  A V Hughson; A F Cooper; C S McArdle; D C Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

2.  Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.

Authors:  Atif J Khan; Matthew M Poppe; Sharad Goyal; Kristine E Kokeny; Thomas Kearney; Laurie Kirstein; Deborah Toppmeyer; Dirk F Moore; Chunxia Chen; David K Gaffney; Bruce G Haffty
Journal:  J Clin Oncol       Date:  2017-05-01       Impact factor: 44.544

3.  Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.

Authors:  Pauline T Truong; Ivo A Olivotto; Timothy J Whelan; Mark Levine
Journal:  CMAJ       Date:  2004-04-13       Impact factor: 8.262

4.  Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process.

Authors:  Reshma Jagsi; Paul Abrahamse; Monica Morrow; Jennifer J Griggs; Kendra Schwartz; Steven J Katz
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

5.  Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival.

Authors:  Colin S McArdle; Donald C McMillan; Nicola Greenlaw; David S Morrison
Journal:  BMC Cancer       Date:  2010-07-30       Impact factor: 4.430

6.  Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.

Authors:  Gennifer D Goode; Billy R Ballard; H Charles Manning; Michael L Freeman; Yibin Kang; Sakina E Eltom
Journal:  Int J Cancer       Date:  2013-07-05       Impact factor: 7.396

7.  Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082.

Authors:  Lawrence B Marks; Constance Cirrincione; Thomas J Fitzgerald; Frances Laurie; Arvin S Glicksman; James Vredenburgh; Leonard R Prosnitz; Elizabeth J Shpall; Michael Crump; Paul G Richardson; Michael W Schuster; Jinli Ma; Bercedis L Peterson; Larry Norton; Steven Seagren; I Craig Henderson; David D Hurd; William P Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-09       Impact factor: 7.038

Review 8.  Postmastectomy radiation therapy: an overview for the practicing surgeon.

Authors:  Reshma Jagsi
Journal:  ISRN Surg       Date:  2013-09-11

9.  Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.

Authors:  Yu-Li Su; Shan-Hsuan Li; Yen-Yang Chen; Hui-Chun Chen; Yen Tang; Cheng-Hua Huang; Fong-Fu Chou; Shih-Chung Wu; Kun-Ming Rau
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.